Ajai Chari^1*, Cyrille Touzeau^2*, Carolina Schinke³, Monique C. Minnema, MD, PhD⁴, Jesus Berdeja, MD⁵, Albert Oriol^6*, Niels WCJ Van De Donk, MD⁷, Paula Rodriguez Otero^8*, Elham Askari^9*, Maria-Victoria Mateos, MD¹⁰, Luciano J. Megala Costa, MD, PhD¹¹, Jo Caers, PhD¹², Leo Rasche, MD^13*, Amrita Y. Krishnan, MD, FACP¹⁴, Deeksha Vishwamitra^15*, Xuewen Ma^15*, Xiang Qin^15*, Katharine S. Gries, PhD, PharmD^16*, Michela Campagna^17*, Tara Masterson^15*, Brandi Hilder^15*, Jaszianne Tolbert¹⁵, Thomas Renaud^18*, Jenna D. Goldberg^18*, Christoph Heuck^15*, Jesús San-Miguel, MD, PhD¹⁹ and Philippe Moreau, MD^20*

¹Mount Sinai School of Medicine, New York, NY
²Centre Hospitalier Universitaire de Nantes, Nantes, France
³Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
⁴University Medical Center Utrecht, Utrecht, Netherlands
⁵Sarah Cannon Research Institute, Nashville, TN
⁶Hospital Germans Trias I Pujol, Barcelona, Spain
⁷Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
⁸University of Navarra, Pamplona, Spain
⁹Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
¹⁰University Hospital of Salamanca/IBSAL/CIC, Salamanca, Spain
¹¹University of Alabama at Birmingham, Birmingham, AL
¹²University of Liege, Liege, Belgium
¹³University Hospital of Würzburg, Würzburg, Germany
¹⁴City of Hope Comprehensive Cancer Center, Duarte, CA
¹⁵Janssen Research & Development, Spring House, PA
¹⁶Janssen Global Services, Raritan, NJ
¹⁷Janssen-Cilag, Madrid, Spain
¹⁸Janssen Research & Development, Raritan, NJ
¹⁹Universidad de Navarra, Pamplona, Spain
²⁰University Hospital Hôtel-Dieu, Nantes, France

Noopur Raje, MD¹, Nizar Jacques Bahlis, MD², Caitlin Costello, MD³, Bhagirathbhai Dholaria, MBBS⁴, Melhem Solh, MD⁵, Moshe Yair Levy, MD⁶, Michael H Tomasson, MD^7*, Michael A. Damore, PhD^8*, Sibo Jiang, PhD^9*, Cynthia Basu, PhD^10*, Athanasia Skoura, PhD^11*, Edward M Chan, MD^12*, Suzanne Trudel¹³, Andrzej Jakubowiak, MD, PhD^14*, Michael P Chu, MD^15*, Cristina J. Gasparetto, MD¹⁶, Andrew P. Dalovisio, MD¹⁷, Michael Sebag, MD, PhD¹⁸ and Alexander M Lesokhin, MD¹⁹

¹Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
²Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
³Moores Cancer Center, University of California San Diego, La Jolla, CA
⁴Vanderbilt University Medical Center and Vanderbilt- Ingram Cancer Center, Nashville, TN
⁵Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA
⁶Department of Medical Oncology, Baylor Scott and White Health, Dallas, TX
⁷Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
⁸Oncology Research and Development, Pfizer, San Diego, CA
⁹Early Clinical Development, Pfizer Inc, San Diego, CA
¹⁰Early Clinical Development, Pfizer, San Diego, CA
¹¹Early Clinical Development, Pfizer, Collegeville, PA
¹²Oncology Research and Development, Pfizer, South San Francisco, CA
¹³Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁴Department of Medicine, University of Chicago Medical Center, Chicago, IL
¹⁵Cross Cancer Institute, Edmonton, AB, Canada
¹⁶Department of Medicine, Duke University Cancer Institute, Durham, NC
¹⁷Department of Hematology and Oncology, Ochsner Health, Jefferson, LA
¹⁸Cedars Cancer Center, McGill University Health Centre, Montreal, QC, Canada
¹⁹Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, NY

Nizar Jacques Bahlis, MD¹, Michael H. Tomasson, MD², Mohamad Mohty, MD PhD³, Ruben Niesvizky, MD⁴, Ajay K. Nooka, MD, MPH, FACP⁵, Salomon Manier, MD, PhD⁶, Christopher Maisel, MD⁷, Yogesh Jethava, MD^8*, Joaquin Martinez-Lopez, MD, PhD^9*, H Miles Prince, MD¹⁰, Bertrand Arnulf^11*, Paula Rodriguez Otero^12*, Guenther Koehne, MD, PhD¹³, Cyrille Touzeau^14*, Noopur Raje, MD¹⁵, Shinsuke Iida, MD, PhD¹⁶, Marc-Steffen Raab^17*, Eric Leip, PhD^18*, Sharon Sullivan, PhD^19*, Umberto Conte, PharmD^20*, Andrea Viqueira, MD^21* and Alexander M Lesokhin, MD²²

¹Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
²Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
³Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
⁴Division of Hematology & Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁵Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁶CHU de Lille, Lille, France
⁷Baylor University Medical Center, Dallas, TX
⁸Indiana Blood & Marrow Transplantation, Indianapolis, IN
⁹Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁰Epworth Healthcare, Melbourne, Australia
¹¹Hôpital Saint-Louis, Paris, France
¹²Clinica Universidad de Navarra, Pamplona, Spain
¹³Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health, Miami, FL
¹⁴Centre Hospitalier Universitaire (CHU) de Nantes, INSERM, Université de Nantes, Nantes, France
¹⁵Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
¹⁶Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
¹⁷Heidelberg Myeloma Center, Department of Hematology/Oncology, Heidelberg University Hospital, Heidelberg, Germany
¹⁸Pfizer Inc., Cambridge, MA
¹⁹Pfizer Inc, Cambridge, MA
²⁰Pfizer Inc, New York, NY
²¹Pfizer SLU, Madrid, Spain
²²Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, NY

Emma Searle^1*, Hang Quach², Sandy W. Wong, MD³, Luciano J. Megala Costa, MD, PhD⁴, Cyrille Hulin^5*, Wojciech Janowski^6*, Jesus Berdeja, MD⁷, Sébastien Anguille^8*, Jeffrey V. Matous, MD⁹, Cyrille Touzeau^10*, Anne-Sophie Michallet, MD, PhD^11*, Marla Husnik^12*, Deeksha Vishwamitra^13*, Zhuolu Niu^14*, Julie Larsen^15*, Lingling Chen^13*, Jenna D. Goldberg^16*, Rakesh Popat^17* and Andrew Spencer¹⁸

¹The University of Manchester, Manchester, United Kingdom
²University of Melbourne, St. Vincent’s Hospital Melbourne, Melbourne, VIC, Australia
³UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
⁴University of Alabama at Birmingham Hospital, Vestavia, AL
⁵Hôpital Haut Leveque, University Hospital, Pessac, France
⁶Calvary Mater Newcastle, Waratah, NSW, Australia
⁷Sarah Cannon Research Institute, Nashville, TN
⁸Vaccine and Infectious Disease Institute, University of Antwerp, Edegem, Belgium, Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium
⁹Colorado Blood Cancer Institute, Denver, CO
¹⁰Centre Hospitalier Universitaire de Nantes, Nantes, France
¹¹Centre Hospitalier Lyon Sud, Hospices Civils, LYON, France
¹²Janssen Research & Development, San Diego, CA
¹³Janssen Research & Development, Spring House, PA
¹⁴Janssen Research & Development, Shanghai, China
¹⁵Janssen Research & Development, Los Angeles, CA
¹⁶Janssen Research & Development, Raritan, NJ
¹⁷University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁸Monash University, Melbourne, Australia

Carmelo Carlo-Stella, MD, PhD¹, Rita Mazza, MD^2*, Salomon Manier, MD, PhD³, Thierry Facon^3*, Sung-Soo Yoon, MD, PhD^4,5, Youngil Koh, MD, PhD^5*, Simon J Harrison, MD^6,7, Jeremy Er, MD^8,9*, Antonio Pinto, MD^10*, Francesco Volzone, MD^10*, Giulia Perrone, MD^11*, Paolo Corradini, MD¹¹, Titouan Cazaubiel, MD^12*, Cyrille Hulin^12*, Cyrille Touzeau^13*, Philippe Moreau, MD^14*, Enrique M. Ocio¹⁵, Carmen Maria Montes Gaisan, MD^15*, Rakesh Popat, MD, PhD^16*, Sarah Leong, MD^16*, Fritz Offner, MD, PhD¹⁷, Paula Rodriguez Otero^18*, Ana Alfonso-Pierola, MD, PhD^19*, Ann-Marie E Bröske^20*, Iryna Dekhtiarenko, PhD^21*, Hans-Joachim Helms, PhD^22*, Sara Belli, PhD^22*, Eva Rossmann, MD, PhD^22*, Tanja Fauti, PhD^21*, Jan Eckmann^20*, Tom Moore, MD^20*, Meike Schneider, MD^22*, Wolfgang Jacob, PhD^20*, Martin Weisser, MD, PhD^20*, Martin Hutchings, MD, PhD^23* and Caroline Hasselbalch Riley, MD, PhD^23*

¹Department of Oncology and Hematology, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
²Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
³CHU de Lille, Lille, France
⁴Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
⁵Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁶Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
⁷Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia
⁸The Walter and Eliza Hall Institute of Medical Research and Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
⁹Department of Clinical Haematology, Peter MacCallum Cancer Center and Royal Melbourne Hospital, Melbourne, Australia
¹⁰Istituto Nazionale dei Tumori “Fondazione G Pascale”, IRCCS, Napoli, Italy
¹¹IRCCS Istituto Nazionale dei Tumori, Milan, Italy
¹²CHU de Bordeaux, Bordeaux, France
¹³Centre Hospitalier Universitaire (CHU) de Nantes, INSERM, Université de Nantes, Nantes, France
¹⁴CHU de Nantes, Nantes, France
¹⁵Hospital Universitario Marques de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
¹⁶University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁷Universitair Ziekenhuis Gent, Gent, Belgium
¹⁸Clinica Universidad de Navarra, Navarra, Spain
¹⁹Department of Hematology, Clinica Universidad de Navarra, Navarra, Spain
²⁰Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany
²¹Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Zurich, Switzerland
²²Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland
²³Rigshospitalet, Copenhagen, Denmark

Sandy W. Wong, MD¹, Noffar Bar, MD², Laura Paris, MD^3*, Craig C Hofmeister, MD⁴, Markus Hansson, MD^5*, Armando Santoro, MD^6,7*, Maria-Victoria Mateos, MD⁸, Paula Rodríguez-Otero, MD, PhD^9*, Johan Lund, MD^10*, Cristina Encinas, MD^11*, Andrew J. Yee, MD¹², Albert Oriol, MD^13*, Claudio Cerchione, MD¹⁴, Javier de la Rubia, MD^15*, Barbara Ferstl, MD^16*, Kristina Carlson, MD¹⁷, Paz Ribas, MD^18*, Arancha Bermúdez, MD^19*, Isaac W. Boss, PhD^20*, Allison Gaudy, PhD^21*, Shaoyi Li, PhD^22*, Kevin Hsu, PharmD^23*, Colin D. Godwin, MD, MPhil²⁴, Michael R. Burgess, MD, PhD²⁵, Jesús San-Miguel, MD, PhD²⁶ and Luciano J. Megala Costa, MD, PhD²⁷

¹Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA
²Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, CT
³Hematology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
⁴Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁵Skåne University Hospital, Lund, Sweden
⁶Department of Biomedical Sciences, Humanitas University, Milan, Italy
⁷IRCCS Humanitas Research Hospital - Humanitas Cancer Center Rozzano, Milan, Italy
⁸Department of Hematology, and Center for Cancer Research, University Hospital of Salamanca, Salamanca, Spain
⁹Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain
¹⁰Haematology Center, Karolinska University Hospital, Stockholm, Sweden
¹¹Hematology Department, Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain
¹²Massachusetts General Hospital Cancer Center, Boston, MA
¹³Institut Josep Carreras and Institut Catala d’Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁴Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy
¹⁵Hematology Department, University Hospital La Fe, Valencia, Spain
¹⁶Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
¹⁷Department of Hematology, Uppsala University Hospital, Uppsala, Uppsala Laen, Sweden
¹⁸Department of Hematology, Hospital Universitario Dr Peset Aleixandre, Valencia, Spain
¹⁹Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
²⁰Translational Research, Bristol Myers Squibb, Seattle, WA
²¹Clinical Pharmacology and Pharmacometrics, Bristol Myers Squibb, Summit, NJ
²²Biostatistics, Bristol Myers Squibb, Berkley Heights, NJ
²³Early Clinical Development, Bristol Myers Squibb, Summit, NJ
²⁴Early Clinical Development, Bristol Myers Squibb, Seattle, WA
²⁵Early Clinical Development, Bristol Myers Squibb, Princeton, NJ
²⁶Applied Medical Research, Clínica Universidad de Navarra, Pamplona, Spain
²⁷University of Alabama at Birmingham Hospital, Vestavia, AL